Interpretation of the Disk Diffusion Susceptibility Test for Amikacin: Report of a Collaborative Study

Author:

Washington John A.1,Yu Pauline K. W.1,Gavan Thomas L.2,Schoenknecht Fritz D.3,Thornsberry Clyde4

Affiliation:

1. Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901

2. Cleveland Clinic Foundation, Cleveland, Ohio 44106

3. University of Washington, Seattle, Washington 98195

4. Center for Disease Control, Atlanta, Georgia 30333

Abstract

Because excessively high rates of false resistance have been encountered with the 10-μg amikacin disk in diffusion susceptibility tests, a study was performed to examine existing zone diameter interpretative criteria and to compare the accuracy of 10- and 30-μg amikacin disks by the error rate-bounded classification scheme. Although current zone diameter interpretative criteria eliminate false susceptibles, there is an unacceptably high rate of false resistants. This problem can be resolved in most instances by revising the zone diameter interpretative criteria for the 10-μg disk (resistant, ≤9 mm; indeterminate, 10 to 11 mm; susceptible, ≥12 mm) or, preferably, by replacing the 10-μg disk with a 30-μg disk and adopting new interpretative criteria (resistant, ≤14 mm; indeterminate, 15 to 16 mm; susceptible, ≥17 mm). Because of significant differences in performance among media, it is necessary to include Pseudomonas aeruginosa ATCC 27853 among controls routinely tested and to exclude from use lots of Mueller-Hinton agar yielding results outside the 75% tolerance (90% confidence) limits for amikacin.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference20 articles.

1. Antibiotic susceptibility testing by a standardized single disk method;Bauer A. W.;Am. J. Clin. Pathol.,1966

2. Eisenhart C. M. W. Hastay and W. A. WallHs. 1947. Selected techniques of statistical analysis for scientific and industrial research and production and management engineering p. 97-110. McGraw-Hill Book Co. New York.

3. Advances in aminoglycoside therapy: amikacin;Finland M.;J. Infect. Dis.,1976

4. Rules and regulations: antibiotic susceptibility discs;Food and Drug Administration;Fed. Regist.,1972

5. Rules and regulations: antibiotic susceptibility discs-correction;Food and Drug Administration;Fed. Regist.,1973

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3